Discover 1,190 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,190
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for
Multiple Myeloma
Location: Cincinnati OH, Indianapolis IN, Cleveland OH,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06152575
Phase 3, Recruiting
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
for
Full Aniridia, Partial Aniridia
Location: Cincinnati OH, Philadelphia PA, Los Angeles CA
Sponsor: Clinical Research Consultants, Inc.
Sex: All
Age: 3+
Code: NCT01860612
Recruiting
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
for
Stargardt Disease, Cone Rod Dystrophy,
Location: Cincinnati OH, Ann Arbor MI, Philadelphia PA, Boston MA,
Sponsor: Ascidian Therapeutics, Inc
Sex: All
Age: 12+
Code: NCT06467344
Phase 1, Phase 2, Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Cincinnati OH, Carmel IN, Cleveland OH, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase 2, Phase 3, Recruiting
Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
for
Proliferative Vitreoretinopathy,
Location: Cincinnati OH
Sponsor: Cincinnati Eye Institute, Southwest Ohio
Sex: All
Age: 18+
Code: NCT06541574
Phase 2, Recruiting
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Cincinnati OH, Southaven MS, Dallas TX, Phoenix AZ
Sponsor: Astellas Institute for Regenerative Medicine
Sex: All
Age: 6+
Code: NCT07734064
Phase 1, Recruiting
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
for
Macular Telangiectasia Type 2 (MacTel)
Location: Cincinnati OH, Cleveland OH, Grand Rapids MI,
Sponsor: Neurotech Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06971939
Recruiting
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Cincinnati OH, Ann Arbor MI, Pittsburgh PA, Chicago IL,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 6+
Code: NCT07425574
Recruiting
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
for
ARB, BVMD, Autosomal-Dominant Bestrophinopathy,
Location: Cincinnati OH, New York NY, Dallas TX, Los Angeles CA
Sponsor: Opus Genetics, Inc
Sex: All
Age: 18+
Code: NCT07185256
Phase 1, Phase 2, Recruiting
ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty
for
Corneal Transplant Failure
Location: Cincinnati OH, Indianapolis IN, Ann Arbor MI, Durham NC,
Sponsor: Massachusetts Eye and Ear Infirmary
Sex: All
Age: 18+
Code: NCT06753916
Phase 2, Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Location: Cincinnati OH, Carmel IN, Oak Forest IL,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 50+
Code: NCT07064759
Phase 3, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy